DeHealth Web3 and DHLT: Project History, Facts and Primary Sources

1. Why DeHealth explored Web3

DeHealth was founded on a simple observation: health data is generated by the individual, but in practice control over it is dispersed among healthcare providers, insurers, technology platforms and other intermediaries. The person the data concerns usually has the least say in who uses it and how.

One of DeHealth's early product hypotheses was to give users more control over their own health data: the ability to keep their medical history in one place, to manage access to it, and, by separate and voluntary consent, to take part in models for sharing anonymised data with researchers and the healthcare industry.

In 2021-2022 the team explored Web3 as one possible technological and economic mechanism for that idea: decentralised storage, cryptographic access control held by the user, and a token as the unit of account within the model.

The idea was not for DeHealth to sell users' health data. The hypothesis was the opposite: to shift control towards the individual and let each person decide whether to grant access to specific anonymised data, and on what terms.

2. What DHLT was, and what it was not

DHLT (originally branded HLT) was the utility token of DeHealth's experimental Web3 model. It was intended for use within that model and was distributed through an Initial DEX Offering on 18 to 21 February 2022 across several launchpads.

What DHLT was not. It was not a share, an equity interest or an investment product, and it carried no right to DeHealth's profits. The token documentation expressly warned purchasers that they could lose the entire amount paid and that no increase in value or return was guaranteed. An archived copy of the whitepaper and token documentation is available for verification on request; once its publication is cleared it will be placed in the evidence library on this page.

DHLT was not a standalone DeHealth business. It was an instrument of one of the models the team was testing. The company existed before the token and continued to operate after the token-linked model was retired.

3. What proved difficult to scale

It was an ambitious model, and implementing it proved more complex than the original technical concept. Scaling it required solving several problems at once, each a substantial task on its own:

• privacy and regulatory compliance: health data is among the most protected categories of personal data, and combining it with crypto-assets created regulatory uncertainty in key jurisdictions;
• user experience: users of a health application need a simple, intelligible product, and the need to handle wallets, keys and a token excluded precisely the people the product was built for;
• token liquidity and dependence on the cryptocurrency market, which sat uneasily with the long-term nature of health data;
• dependence on external Web3 providers, including market makers and decentralised exchanges.

The team also faced a crisis around DHLT's market infrastructure in February 2022, described below, and, days later, Russia's full-scale invasion of Ukraine, after which a significant part of DeHealth's team, users and partners found themselves in wartime conditions.

DeHealth does not hide this chapter of its history. The Web3 model was an entrepreneurial experiment. Some of its original assumptions did not scale as the team expected, and the token-linked model was subsequently retired.

4. The Gotbit engagement and the February 2022 incident

5. The Ukrainian criminal proceeding

On 14 March 2022, following the complaint of Denys Tsvaig, a criminal proceeding was registered under Article 190, part 3, of the Criminal Code of Ukraine (fraud). In the available procedural documents, Denys Tsvaig and Anna Bondarenko are recorded as injured parties, not as suspects or defendants.

The extract from the Unified Register of Pre-trial Investigations and the documents recording procedural status are available to professional counterparties and the media for verification on request.

6. What the US prosecution of Gotbit established

The US Department of Justice, District of Massachusetts, prosecuted Gotbit Consulting LLC and Aleksei Andriunin as part of Operation Token Mirrors.

In its plea agreement Gotbit admitted that between 2018 and 2024 it provided market-manipulation services, including wash trading, to create artificial trading volume for cryptocurrency clients, that it publicly marketed these services as “market making”, and that client payments were contractually conditioned on meeting minimum trading-volume targets. The court filings name specific client tokens, including Robo Inu and Saitama, as examples of that conduct.

7. What the US case does not establish

• The public US case did not investigate DHLT.
• The public DOJ materials reviewed by DeHealth (the indictment and sentencing announcements, both plea agreements and the forfeiture complaint) do not mention DeHealth or DHLT.
• The US prosecution should not be presented as a judicial finding concerning the DHLT incident of 22 February 2022. DeHealth does not present it as such.
• Blockchain transactions alone do not attribute control of a wallet to a person or company without separate evidence establishing that attribution.

DeHealth does not claim the US investigation as its own and does not assert that a US court examined DHLT.

8. How DeHealth evolved after Web3

The product continued to develop without the token model. The underlying idea did not change: individual control over one's own data remains the foundation of the product, but it is delivered by other means. Today the DeHealth product operates as an AI preventive-health platform; access to data is governed by user consent and data-protection law, with no token and no blockchain as a required element for the user.

Corporate structure. The operating company is DeHealth Technologies Inc., Delaware, with its principal office at 1049 El Monte Avenue, Ste C #846, Mountain View, CA 94040. DeHealth UK Ltd, Companies House 13472275, incorporated on 23 June 2021, holds the UK presence; its most recent filed accounts are dormant.

Status of the founders. We are not aware of any criminal proceeding in any jurisdiction in which Anna Bondarenko or Denys Tsvaig has been charged in connection with DHLT or DeHealth. In the Ukrainian proceeding both are recorded as injured parties. DeHealth and its founders were not defendants in the US prosecution of Gotbit.

Anna Bondarenko has separately exercised rights available to her under Article 17 GDPR in relation to certain search results. That process is distinct from the criminal proceedings described on this page.

9. Evidence library

Tier 5. DeHealth's own account: this page. The more important the claim, the higher the tier of evidence behind it.

10. Questions and answers